Next report date
Report period
Q1 2024
EPS estimate
−1.05USD
Revenue estimate
—
−98.15 MUSD
25.73 M
About CARGO Therapeutics, Inc.
Sector
Industry
CEO
Gina Chapman
Website
Headquarters
San Mateo
Founded
2019
FIGI
BBG01D59LY25
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Mateo, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CRGX is 20.54 USD — it has increased by 7.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CARGO Therapeutics, Inc. stocks are traded under the ticker CRGX.
CARGO Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CRGX stock is 10.60% volatile and has beta coefficient of 0.90. Check out the list of the most volatile stocks — is CARGO Therapeutics, Inc. there?
CRGX earnings for the last quarter are −47.37 USD per share, whereas the estimation was −3.37 USD resulting in a −1.31 K% surprise. The estimated earnings for the next quarter are −1.62 USD per share. See more details about CARGO Therapeutics, Inc. earnings.
Yes, you can track CARGO Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CRGX stock has risen by 8.97% compared to the previous week, the month change is a 7.97% fall, over the last year CARGO Therapeutics, Inc. has showed a 32.94% increase.
CRGX net income for the last quarter is −32.08 M USD, while the quarter before that showed −35.47 M USD of net income which accounts for 9.57% change. Track more CARGO Therapeutics, Inc. financial stats to get the full picture.
No, CRGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARGO Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on CARGO Therapeutics, Inc. future price: according to them, CRGX price has a max estimate of 32.00 USD and a min estimate of 30.00 USD. Read a more detailed CARGO Therapeutics, Inc. forecast: see what analysts think of CARGO Therapeutics, Inc. and suggest that you do with its stocks.